As of March 31, 2020, MeVis Medical Solutions AG has 1.82M shares outstanding.
| Shares Outstanding | 1.82M |
As of March 31, 2020, MeVis Medical Solutions AG maintains a current ratio of 1.65, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.65 |
| Quick Ratio | 0.62 |
These figures cover the twelve months ended March 31, 2020.
| Employee Count | 105.00 |
Over the twelve months ended March 31, 2020, MeVis Medical Solutions AG recorded 85,000.00 in income tax expense.
| Income Tax | 85,000.00 |
As of the close on October 22, 2026, MeVis Medical Solutions AG's stock has declined approximately 13.93% over the past 52 weeks. The 50-day moving average sits at 22.57, while the 200-day moving average is 23.14.
| 52-Week Price Change | -13.93% |
| 50-Day Moving Average | 22.57 |
| 200-Day Moving Average | 23.14 |
These figures are as of March 31, 2020. Total book value stands at 17.83M, with working capital of 3.18M providing operational flexibility.
| Cash & Cash Equivalents | 3.05M |
| Net Debt | -3.05M |
| Equity (Book Value) | 17.83M |
| Book Value Per Share | 9.79 |
| Working Capital | 3.18M |
These figures cover the twelve months ended March 31, 2020.
| Capital Expenditures | -195,922.14 |
Already premium?